gtm-deal-pulse

Assess pipeline health by scoring active deals across 16 signals in four pillars to produce evidence-graded health assessments. This generates a 0-100 deal health score, identifies top risks, and recommends next actions mapped to your sales methodology.

Evidence-based deal scoring evaluates opportunity health by analyzing CRM data, call transcripts, emails, and activity history. Each of the 16 pipeline signals is graded as GREEN, YELLOW, or RED with multi-sentence justifications citing specific evidence.

Yes, you can identify sales pipeline risks by pulling CRM data, call transcripts, emails, and activity history. The assessment highlights critical risks with multi-sentence justifications citing specific evidence from these sources to guide intervention efforts.

Prepare for a weekly sales forecast call by running an evidence-based assessment of your team's pipeline. This scores active deals from 0-100, categorizes risk levels, and recommends next actions so managers can focus intervention efforts on Medium or High Risk deals.

Yes, deal scoring works with your existing sales methodology by mapping identified risks to specific actions for reps and managers. It evaluates deals across four pillars—Why Anything, Why Us, Why Now, and Execution—and aligns recommendations with your methodology.